☆ 4.5 Article

TACC3 is an independent prognostic marker, and knockdown of TACC3 enhances the efficacy of CDK1 inhibitor RO3306 in liver cancer cells

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Gastroenterology & Hepatology

Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Nicole E. Rich et al.

Summary: Overdiagnosis refers to the detection of diseases that would not have become apparent during a patient's lifetime. It can have serious negative consequences including overtreatment, financial toxicity, and psychological harm. Overdiagnosis can occur due to inaccurate diagnostic criteria, early detection of malignant lesions, indolent tumors, and competing risks of mortality. Guideline recommendations can help mitigate the risk, but more research is needed to understand and reduce overdiagnosis.

HEPATOLOGY (2022)

添加到收藏夹

Article Oncology

Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data

Uasim Harkus et al.

Summary: This review discusses the pathophysiology of hepatocellular carcinoma (HCC), the tumor microenvironment, key clinical trials evaluating immune checkpoint inhibitors (ICIs) in HCC, various resistance mechanisms to ICIs, and possible ways to overcome these impediments to improve patient outcomes.

SEMINARS IN CANCER BIOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options

Friedrich Foerster et al.

Summary: Given the global increase in obesity and type 2 diabetes, non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are becoming important causes of hepatocellular carcinoma (HCC). HCCs caused by chronic inflammation mediated by lipotoxicity have unique characteristics, such as occurring in up to 50% of NAFLD-HCC patients without cirrhosis and having a lower annual incidence, leading to challenges in surveillance strategies. Locoregional treatments may be equally effective regardless of HCC etiology, but the effectiveness of systemic therapy is less clear. Tyrosine kinase inhibitors are likely equally effective, while there are initial signals that immune checkpoint inhibitors may be less effective in NAFLD-HCC compared to viral HCC.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

添加到收藏夹

Review Oncology

CDK1 in Breast Cancer: Implications for Theranostic Potential

Sepideh Izadi et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Oncology

A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate

Ozge Akbulut et al.

MOLECULAR CANCER THERAPEUTICS (2020)

添加到收藏夹

Article Cell Biology

SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway

Guoqing Wan et al.

CELLULAR SIGNALLING (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs

Robert Roskoski

PHARMACOLOGICAL RESEARCH (2019)

添加到收藏夹

Article Oncology

Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma

Hongyan Li et al.

CANCER MANAGEMENT AND RESEARCH (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of TACC3 by a small molecule inhibitor in breast cancer

Loredana Campo et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3)

Jung-Lye Kim et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mitotic spindle association of TACC3 requires Aurora-A-dependent stabilization of a cryptic alpha-helix

Selena G. Burgess et al.

EMBO JOURNAL (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Alteronol induces cell cycle arrest and apoptosis via increased reactive oxygen species production in human breast cancer T47D cells

Boxue Ren et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)

添加到收藏夹

Article Cell Biology

TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer

Zhi-Rui Lin et al.

CELL DEATH & DISEASE (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma

Chuan Xing Wu et al.

THERANOSTICS (2018)

添加到收藏夹

Article Medicine, General & Internal

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties

Jialin Cai et al.

EBIOMEDICINE (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Overexpression of TACC3 is correlated with tumor aggressiveness and poor prognosis in prostate cancer

Qiji Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

TACC3 Is Important for Correct Progression of Meiosis in Bovine Oocytes

Mahdi Mahdipour et al.

PLOS ONE (2015)

添加到收藏夹

Article Oncology

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma

Dong-Sheng Zhou et al.

ONCOTARGET (2015)

添加到收藏夹

Article Genetics & Heredity

Aurora-A-Dependent Control of TACC3 Influences the Rate of Mitotic Spindle Assembly

Selena G. Burgess et al.

PLOS GENETICS (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells

R. Yao et al.

ONCOGENE (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

添加到收藏夹

Review Oncology

Transforming acidic coiled-coil proteins (TACCs) in human cancer

Geun-Hyoung Ha et al.

CANCER LETTERS (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Risk stratification for hepatitis B virus related hepatocellular carcinoma

Chih-Lin Lin et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma

Devendra Singh et al.

SCIENCE (2012)

添加到收藏夹

Review Public, Environmental & Occupational Health

Hepatitis B prevention, diagnosis, treatment and care: a review

E. J. Aspinall et al.

OCCUPATIONAL MEDICINE-OXFORD (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B-Related Hepatocellular Carcinoma

Yoshiaki Mizuguchi et al.

PLOS ONE (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program

S. Schmidt et al.

ONCOGENE (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest

L. Schneider et al.

ONCOGENE (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.